Marilanda Ferreira Bellini

Marilanda Ferreira Bellini

Auto-generated profile, based on publicly available information

Marilanda Ferreira Bellini

Univ Sagrado Coracao, Ctr Ciencias Saude, Bauru, SP, Brazil

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Mutation Research - Reviews in Mutation Research
Verified
Journal Article
Closed access
MMMário S. Mantovani
Mário S. Mantovani
MBMarilanda F. Bellini
Marilanda F. Bellini
JAJosé Pedro F. Angeli
José Pedro F. Angeli
RORodrigo J. Oliveira
Rodrigo J. Oliveira
ASAriane F. Silva
Ariane F. Silva
LRLúcia R. Ribeiro
Lúcia R. Ribeiro

1 January 2012 in Journal of Biomedicine and Biotechnology
Verified
Journal Article
Open access
PDF file
MBMarilanda Ferreira Bellini
Marilanda Ferreira Bellini
ACAline Cristina Targa Cadamuro
Aline Cristina Targa Cadamuro
MSMaysa Succi
Maysa Succi
MPMarcela Alcântara Proença
Marcela Alcântara Proença
ASAna Elizabete Silva
Ana Elizabete Silva
TP53genes is one of more important tumor suppressor gene, which acts as a potent transcription factor with fundamental role in the maintenance of genetic stability. The development of esophageal and gastric cancers is a multistep process resulting in successive accumulation of genetic alterations that culminates in the malignant transformation. Thus, this study highlights the participation of the main genetic alterations of theTP53gene in esophageal and gastric carcinogenesis. Among these changes, high frequency ofTP53mutations, loss of heterozygosity (LOH), overexpression of the p53 protein, and consequently loss of p53 function, which would be early events in esophageal and gastric cancers, as well as an important biomarker of the prognosis and treatment response. Furthermore, Single Nucleotide Polymorphisms (SNPs) ofTP53have been implicated in the development and prognosis of several cancers, mainlyTP53codon 72 polymorphism whose role has been extensively studied in relation to susceptibility for esophageal and gastric cancer development.

5 June 2008 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
JAJosé Pedro Friedmann Angeli
José Pedro Friedmann Angeli
LRLúcia Regina Ribeiro
Lúcia Regina Ribeiro
MBMarilanda Ferreira Bellini
Marilanda Ferreira Bellini
MMMário Sérgio Mantovani
Mário Sérgio Mantovani

1 April 2006 in Toxicology in Vitro
Verified
Journal Article
Closed access
MBM.F. Bellini
M.F. Bellini
JAJ.P.F. Angeli
J.P.F. Angeli
RMR. Matuo
R. Matuo
ATA.P. Terezan
A.P. Terezan
LRL.R. Ribeiro
L.R. Ribeiro
MMM.S. Mantovani
M.S. Mantovani

7 May 2003 in Toxicology in Vitro
Verified
Journal Article
Closed access
MBM.F. Bellini
M.F. Bellini
NGN.L. Giacomini
N.L. Giacomini
AEA.F. Eira
A.F. Eira
LRL.R. Ribeiro
L.R. Ribeiro
MMM.S. Mantovani
M.S. Mantovani

8 March 2012 in Journal of Tropical Medicine
Verified
Journal Article
Open access
PDF file
MBMarilanda Ferreira Bellini
Marilanda Ferreira Bellini
RSRosana Silistino-Souza
Rosana Silistino-Souza
MVMarileila Varella-Garcia
Marileila Varella-Garcia
Jader de OliveiraJader de Oliveira
Jader de Oliveira
ASAna Elizabete Silva
Ana Elizabete Silva
The etiologic agent of Chagas Disease is theTrypanosoma cruzi, transmitted through blood-sucking insect vectors of the Triatominae subfamily, representing one of the most serious public health concerns in Latin America. There are geographic variations in the prevalence of clinical forms and morbidity of Chagas disease, likely due to genetic variation of theT. cruziand the host genetic and environmental features. Increasing evidence has supported that inflammatory cytokines and chemokines are responsible for the generation of the inflammatory infiltrate and tissue damage. Moreover, genetic polymorphisms, protein expression levels, and genomic imbalances are associated with disease progression. This paper discusses these key aspects. Large surveys were carried out in Brazil and served as baseline for definition of the control measures adopted. However, Chagas disease is still active, and aspects such as host-parasite interactions, genetic mechanisms of cellular interaction, genetic variability, and tropism need further investigations in the attempt to eradicate the disease.